Log in or create an account for full access to this data.
Create a free account or log in to use this tool.
Create a free account or log in to explore DrugBank data.
Carphenazine is an antipsychotic drug, used in hospitalized patients in the management of chronic schizophrenic psychoses.
- Mechanism
- Curator reviewed
A yellow, powdered, phenothiazine antipsychotic agent used in the treatment of acute or chronic schizophrenia. The term "phenothiazines" is used to describe the largest of the five main classes of neuroleptic antipsychotic drugs. These drugs have antipsychotic and, often, antiemetic properties, although they may also cause severe side effects such as akathisia, tardive dyskinesia and extrapyramidal symptoms. Carphenazine blocks postsynaptic mesolimbic dopaminergic D1 and D2 receptors in the brain; depresses the release of hypothalamic and hypophyseal hormones and is believed to depress the reticular activating system thus affecting basal metabolism, body temperature, wakefulness, vasomotor tone, and emesis.
- Primary indication
- Used in the treatment of acute or chronic schizophrenic reactions in hospitalized patients.Curator reviewed
- Formula / weight
- C24H31N3O2S · 425.59 g/mol (avg)
- Also known as
- Carfenazine
Resolves to
XZSMZRXAEFNJCU-UHFFFAOYSA-NSMILESCCC(=O)C1=CC=C2SC3=C(C=CC=C3)N(CCCN3CCN(CCO)CC3)C2=C1What you can answer from here — as of September 13, 2026
Which drugs share a target with Carphenazine, and which of those have an active Phase 3 trial?